What is Cannalysis?
Founded in 2015 and headquartered in Santa Ana, California, Cannalysis operates as a licensed cannabis and hemp testing laboratory. The company leverages its deep domain expertise alongside proprietary technology to offer a comprehensive suite of testing services. These services are crucial for ensuring that consumer-facing cannabis and hemp products meet or exceed stringent regulatory compliance standards.
How much funding has Cannalysis raised?
Cannalysis has raised a total of $23M across 2 funding rounds:
Angel/Seed
$1M
Series A
$22M
Angel/Seed (2017): $1M with participation from Casa Verde Capital
Series A (2019): $22M, investors not publicly disclosed
Key Investors in Cannalysis
Casa Verde Capital
Casa Verde Capital is a venture capital firm exclusively focused on the cannabis industry, investing in scalable businesses led by strong management teams to address long-term market needs.
What's next for Cannalysis?
The recent major strategic investment signals a pivotal growth phase for Cannalysis. This capital infusion is expected to fuel expansion initiatives, potentially including the enhancement of its technological infrastructure, broadening its service offerings, and increasing its market reach within the highly regulated cannabis testing sector. The company's focus on compliance and quality positions it for continued success as the industry matures.
See full Cannalysis company page
